Literature DB >> 26110715

Guidelines for the automated evaluation of Elispot assays.

Sylvia Janetzki1, Leah Price2, Helene Schroeder3, Cedrik M Britten4, Marij J P Welters5, Axel Hoos6.   

Abstract

The presented protocol for Elispot plate evaluation summarizes how to implement the recommendations developed following the establishment of a large-scale international Elispot plate-reading panel and subsequent multistep consensus-finding process. The panel involved >100 scientists from various immunological backgrounds. The protocol includes the description and justification of steps for setting reading parameters to obtain accurate, reliable and precise automated analysis results of Elispot plates. Further, necessary adjustments for out-of-specification situations are described and examples are provided. The plate analysis, including parameter adjustments, auditing of results and necessary annotations, should be achievable within a time range of 10-30 min per plate. Adoption of these guidelines should enable a further reduction in assay variability and an increase in the reliability and comparability of results obtained by Elispot. These guidelines conclude the ongoing harmonization efforts for the enzymatic Elispot assay.

Mesh:

Substances:

Year:  2015        PMID: 26110715     DOI: 10.1038/nprot.2015.068

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  33 in total

1.  SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.

Authors:  Siwen Hu-Lieskovan; Srabani Bhaumik; Kavita Dhodapkar; Jean-Charles J B Grivel; Sumati Gupta; Brent A Hanks; Sylvia Janetzki; Thomas O Kleen; Yoshinobu Koguchi; Amanda W Lund; Cristina Maccalli; Yolanda D Mahnke; Ruslan D Novosiadly; Senthamil R Selvan; Tasha Sims; Yingdong Zhao; Holden T Maecker
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

2.  A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis.

Authors:  Adam M Swartz; Elizabeth Reap; Pamela Norberg; Robert Schmittling; Sylvia Janetzki; Luis Sanchez-Perez; John H Sampson
Journal:  J Immunol Methods       Date:  2018-05-31       Impact factor: 2.303

3.  The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity.

Authors:  Shiang-Jong Tzeng
Journal:  J Vis Exp       Date:  2016-12-14       Impact factor: 1.355

4.  Sequence diversity between class I MHC loci of African native and introduced Bos taurus cattle in Theileria parva endemic regions: in silico peptide binding prediction identifies distinct functional clusters.

Authors:  Isaiah Obara; Morten Nielsen; Marie Jeschek; Ard Nijhof; Camila J Mazzoni; Nicholas Svitek; Lucilla Steinaa; Elias Awino; Cassandra Olds; Ahmed Jabbar; Peter-Henning Clausen; Richard P Bishop
Journal:  Immunogenetics       Date:  2016-02-06       Impact factor: 2.846

5.  Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations.

Authors:  Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2016-03-11       Impact factor: 84.694

Review 6.  Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity.

Authors:  Stefan Kiesgen; John C Messinger; Navin K Chintala; Zachary Tano; Prasad S Adusumilli
Journal:  Nat Protoc       Date:  2021-02-15       Impact factor: 13.491

7.  Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.

Authors:  Kristen A Batich; Elizabeth A Reap; Gary E Archer; Luis Sanchez-Perez; Smita K Nair; Robert J Schmittling; Pam Norberg; Weihua Xie; James E Herndon; Patrick Healy; Roger E McLendon; Allan H Friedman; Henry S Friedman; Darell Bigner; Gordana Vlahovic; Duane A Mitchell; John H Sampson
Journal:  Clin Cancer Res       Date:  2017-04-15       Impact factor: 12.531

8.  ELISPOT Assay to Measure Peptide-specific IFN-γ Production.

Authors:  Michelle N Wykes; Laurent Renia
Journal:  Bio Protoc       Date:  2017-06-05

9.  Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting.

Authors:  Adham S Bear; Tatiana Blanchard; Joseph Cesare; Michael J Ford; Lee P Richman; Chong Xu; Miren L Baroja; Sarah McCuaig; Christina Costeas; Khatuna Gabunia; John Scholler; Avery D Posey; Mark H O'Hara; Anze Smole; Daniel J Powell; Benjamin A Garcia; Robert H Vonderheide; Gerald P Linette; Beatriz M Carreno
Journal:  Nat Commun       Date:  2021-07-16       Impact factor: 17.694

10.  Investigating Immune Responses to the scAAV9-HEXM Gene Therapy Treatment in Tay-Sachs Disease and Sandhoff Disease Mouse Models.

Authors:  Shalini Kot; Subha Karumuthil-Melethil; Evan Woodley; Violeta Zaric; Patrick Thompson; Zhilin Chen; Erik Lykken; John G Keimel; William F Kaemmerer; Steven J Gray; Jagdeep S Walia
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.